These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9170426)

  • 1. Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351).
    Chengazi VU; Feneley MR; Ellison D; Stalteri M; Granowski A; Granowska M; Nimmon CC; Mather SJ; Kirby RS; Britton KE
    J Nucl Med; 1997 May; 38(5):675-82. PubMed ID: 9170426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capromab Pendetide imaging of prostate cancer.
    Haseman MK; Rosenthal SA; Polascik TJ
    Cancer Biother Radiopharm; 2000 Apr; 15(2):131-40. PubMed ID: 10803318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351.
    Feneley MR; Chengazi VU; Kirby RS; Nimmon CC; Granowska M; Mather SJ; Ellison D; Granowski AR; Britton KE
    Br J Urol; 1996 Mar; 77(3):373-81. PubMed ID: 8814841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of radioimmunoscintigraphy with indium-111-labeled CYT-356 (ProstaScint) scan for evaluation of patients for salvage brachytherapy.
    Fang DX; Stock RG; Stone NN; Krynyckyi BR; Kim CK; Machac J
    Tech Urol; 2000 Jun; 6(2):146-50. PubMed ID: 10798816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
    de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
    Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients.
    Elgamal AA; Troychak MJ; Murphy GP
    Prostate; 1998 Dec; 37(4):261-9. PubMed ID: 9831223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy.
    Murphy GP; Elgamal AA; Troychak MJ; Kenny GM
    Prostate; 2000 Mar; 42(4):315-7. PubMed ID: 10679761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer imaging with a new monoclonal antibody: a preliminary report.
    Sanford E; Grzonka R; Heal A; Helal M; Persky L; Tyson I
    Ann Surg Oncol; 1994 Sep; 1(5):400-4. PubMed ID: 7850541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the serum prostate specific antigen and whole body scintigraphy in prostate cancer patients after prostatectomy.
    Begic A; Kucukalic-Selimovic E; Obralic N; Duric O; Lacevic N; Begovic-Hadzimuratovic S; Skopljak A; Dzubur-Aganovic M
    Med Arh; 2006; 60(1):54-5. PubMed ID: 16425536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma.
    Learoyd DL; Roach PJ; Briggs GM; Delbridge LW; Wilmshurst EG; Robinson BG
    J Nucl Med; 1997 Feb; 38(2):227-30. PubMed ID: 9025742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy.
    Kahn D; Austin JC; Maguire RT; Miller SJ; Gerstbrein J; Williams RD
    Cancer Biother Radiopharm; 1999 Apr; 14(2):99-111. PubMed ID: 10850293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide.
    Hinkle GH; Burgers JK; Neal CE; Texter JH; Kahn D; Williams RD; Maguire R; Rogers B; Olsen JO; Badalament RA
    Cancer; 1998 Aug; 83(4):739-47. PubMed ID: 9708939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation.
    Haseman MK; Reed NL; Rosenthal SA
    Clin Nucl Med; 1996 Sep; 21(9):704-13. PubMed ID: 8879871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indium-111 capromab pendetide (ProstaScint) imaging to detect recurrent and metastatic prostate cancer.
    Petronis JD; Regan F; Lin K
    Clin Nucl Med; 1998 Oct; 23(10):672-7. PubMed ID: 9790041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.
    Serafini AN; Klein JL; Wolff BG; Baum R; Chetanneau A; Pecking A; Fischman AJ; Hoover HC; Wynant GE; Subramanian R; Goroff DK; Hanna MG
    J Clin Oncol; 1998 May; 16(5):1777-87. PubMed ID: 9586891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
    Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
    Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.
    van Dongen GA; Leverstein H; Roos JC; Quak JJ; van den Brekel MW; van Lingen A; Martens HJ; Castelijns JA; Visser GW; Meijer CJ
    Cancer Res; 1992 May; 52(9):2569-74. PubMed ID: 1568225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoscintigraphy with Tc-99m labeled monoclonal antibody 170H.82 in suspected primary, recurrent, or metastatic breast cancer.
    Lind P; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Omann J; Dinges HP; Boniface G
    Clin Nucl Med; 1997 Jan; 22(1):30-4. PubMed ID: 8993870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
    BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence.
    Kahn D; Williams RD; Seldin DW; Libertino JA; Hirschhorn M; Dreicer R; Weiner GJ; Bushnell D; Gulfo J
    J Urol; 1994 Nov; 152(5 Pt 1):1490-5. PubMed ID: 7523704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.